270 related articles for article (PubMed ID: 23653837)
41. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
[TBL] [Abstract][Full Text] [Related]
42. Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination.
Jalilvand S; Shoja Z; Nourijelyani K; Tohidi HR; Hamkar R
J Med Virol; 2015 Feb; 87(2):287-95. PubMed ID: 25156655
[TBL] [Abstract][Full Text] [Related]
43. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
[TBL] [Abstract][Full Text] [Related]
44. National guidelines for management of cervical squamous intraepithelial lesion: A survey of European Federation for colposcopy members.
Grigore M; Cruickshank ME; Nieminen P; Tjalma W; Moss E; Redman C
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():46-50. PubMed ID: 33166797
[TBL] [Abstract][Full Text] [Related]
45. Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.
Zhao C; Amin M; Weng B; Chen X; Kanbour-Shakir A; Austin RM
Arch Pathol Lab Med; 2013 Jul; 137(7):942-7. PubMed ID: 23050808
[TBL] [Abstract][Full Text] [Related]
46. Discrepancy between Cytology and Histology in Cervical Cancer Screening: a Multicenter Retrospective Study (KGOG 1040).
Ouh YT; Park JJ; Kang M; Kim M; Song JY; Shin SJ; Shim SH; Yoo HJ; Lee M; Lee SJ; Shin W; Chong GO; Choi MC; Choi CH; Min KJ
J Korean Med Sci; 2021 Jun; 36(24):e164. PubMed ID: 34155836
[TBL] [Abstract][Full Text] [Related]
47. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
[TBL] [Abstract][Full Text] [Related]
48. Do Infection Patterns of Human Papillomavirus Affect the Cytologic Detection of High-Grade Cervical Lesions on Papanicolaou Tests?
Samimi SA; Mody RR; Goodman S; Luna E; Armylagos D; Schwartz MR; Mody DR; Ge Y
Arch Pathol Lab Med; 2018 Mar; 142(3):347-352. PubMed ID: 29160722
[TBL] [Abstract][Full Text] [Related]
49. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
[No Abstract] [Full Text] [Related]
50. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
[TBL] [Abstract][Full Text] [Related]
51. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; M Redman L; A Boyle J; Norman RJ; Mousa A; Joham AE;
Fertil Steril; 2023 Oct; 120(4):767-793. PubMed ID: 37589624
[TBL] [Abstract][Full Text] [Related]
52. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE
J Clin Endocrinol Metab; 2023 Sep; 108(10):2447-2469. PubMed ID: 37580314
[TBL] [Abstract][Full Text] [Related]
53. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†.
Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE;
Hum Reprod; 2023 Sep; 38(9):1655-1679. PubMed ID: 37580037
[TBL] [Abstract][Full Text] [Related]
54. Management of atypical squamous cells, low-grade squamous intraepithelial lesions, and cervical intraepithelial neoplasia 1.
Boardman LA; Kennedy CM
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):599-614; ix. PubMed ID: 19061819
[TBL] [Abstract][Full Text] [Related]
55. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
Dane C; Batmaz G; Dane B; Cetin A
Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
[TBL] [Abstract][Full Text] [Related]
56. Cytology-based screening for anal intraepithelial neoplasia in women with a history of cervical intraepithelial neoplasia or cancer.
Wohlmuth C; Ghorab Z; Shier M; Tinmouth J; Salit IE; Covens A; Zhang L; Vicus D
Cancer Cytopathol; 2021 Feb; 129(2):140-147. PubMed ID: 33002327
[TBL] [Abstract][Full Text] [Related]
57. Making Sense of Cervical Cancer Screening Guidelines and Recommendations.
Davis M; Feldman S
Curr Treat Options Oncol; 2015 Dec; 16(12):55. PubMed ID: 26467929
[TBL] [Abstract][Full Text] [Related]
58. Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil.
Zeferino LC; Bastos JB; Vale DBAPD; Zanine RM; Melo YLMF; Primo WQSP; Corrêa FM; Val ICCD; Russomano F
Rev Bras Ginecol Obstet; 2018 Jun; 40(6):360-368. PubMed ID: 29874685
[TBL] [Abstract][Full Text] [Related]
59. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
60. Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice.
Rimel BJ; Burke WM; Higgins RV; Lee PS; Lutman CV; Parker L
Gynecol Oncol; 2015 May; 137(2):280-4. PubMed ID: 25735256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
